ERYTECH announces granting of new patent in the United States
23-Oct-2014 -
ERYTECH reports positive Phase III results from its pivotal study with GRASPA(R) in Acute Lymphoblastic Leukemia.Analysis of the primary and first secondary efficacy endpoints of the GRASPALL clinical trial with one year follow up shows that the GRASPIVOTALL (GRASPALL2009-06) clinical trial ...
acute lymphoblastic leukemia
oncology
phase II/III studies